Tracy Weslosky
-
Steve Saviuk, CEO of Valeo Pharma, Discusses Promising Results of COVID-19 Drug Sabizabulin and Revenue Growth in 2023
In this InvestorIntel interview, Tracy Weslosky talks to Valeo Pharma Inc.’s (TSX: VPH | OTCQB: VPHIF) Founder, CEO, and…
-
F3 Uranium’s CEO Dev Randhawa on Rising Uranium Demand and Recent High-Grade Hits at its PLN Property
In this InvestorIntel interview, Tracy Weslosky talks to F3 Uranium Corp.‘s (TSXV: FUU | OTCQB: FUUFF) CEO and…
-
Valeo Pharma’s CEO Steve Saviuk Talks about Record FQ4 & F2022 Revenue Up 274% & 105%, Respectively
In this InvestorIntel interview, Tracy Weslosky talks to Valeo Pharma Inc.’s (TSX: VPH | OTCQB: VPHIF) Founder, CEO,…
-
Greg Fenton on ZenARMOR, Zentek’s novel corrosion protection technology
In this InvestorIntel interview, Tracy Weslosky talks to Zentek Ltd.‘s (NASDAQ: ZTEK | TSXV: ZEN) CEO and Director Greg…
-
Greg Fenton on the impact of Zentek’s HVAC Phase 2 Testing results on Air Filtration
In this InvestorIntel interview, Tracy Weslosky talks to Zentek Ltd.‘s (NASDAQ: ZTEK | TSXV: ZEN) CEO and Director…
-
Bundeep Singh Rangar of Fineqia International talks about bringing innovation to the digital asset economy
In this InvestorIntel interview, Tracy Weslosky talks to Fineqia International Inc.’s (CSE: FNQ) CEO and Director Bundeep Singh Rangar about how…
-
David Regan of Sona Nanotech provides an update on its agreement with Siva Therapeutics to develop cancer treating therapies
In this InvestorIntel interview, Sona Nanotech Inc.’s (CSE: SONA | OTCQB: SNANF) CEO David Regan provides Tracy Weslosky with…
-
Bundeep Singh Rangar of Fineqia International talks about the increase in confidence for digital assets
In this InvestorIntel interview, Tracy Weslosky talks to Fineqia International Inc. (CSE: FNQ) CEO and Director Bundeep Singh…
